Pricing Log in Create free account

Serina Therapeutics, Inc. (SER) vs Sangamo Therapeutics, Inc. (SGMOQ)

Serina Therapeutics, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Serina Therapeutics, Inc. and Sangamo Therapeutics, Inc. are of similar size ($45.5M and $41.9M). Sangamo Therapeutics, Inc. grew revenue faster over the last twelve months: −45.8% against −94.2%. Serina Therapeutics, Inc. has the higher net margin (0.00% vs −356.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Serina Therapeutics, Inc. leads on 9 and Sangamo Therapeutics, Inc. on 6.

Valuation

Metric SER SGMOQ Biotechnology median
P/E n/m n/m 8.50
P/S 160.23 1.24 9.71
P/B 1.55 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 66.04 1.24 9.21
Earnings yield (106.78%) (345.45%) (33.15%)
Free cash flow yield (73.10%) (211.06%) (25.50%)

Profitability

Metric SER SGMOQ Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (357.55%) 0.00%
Net margin 0.00% (356.89%) 0.00%
Free cash flow margin 0.00% (261.76%) 0.00%
Return on equity (306.22%) 1,755.72% (56.36%)
Return on assets (136.00%) (168.79%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SER SGMOQ Biotechnology median
Revenue growth (TTM) (94.21%) (45.80%) 6.02%
EPS growth (last fiscal year) (26.49%) 10.20% 30.26%
Revenue growth, 5-year CAGR (18.48%) (19.66%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SER SGMOQ Biotechnology median
Debt to equity 0.16 0.00 0.00
Current ratio 6.65 0.70 4.72
Net debt to EBITDA 0.00 0.18 0.96

Dividend

Metric SER SGMOQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SER SGMOQ Biotechnology median
Market cap 45.46m 41.89m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack